Use of CO2 to deactivating a cellulolytic microorganism used in the biochemical conversion of lignocellulosic materials
US-10150980-B2 · Dec 11, 2018 · US
US2017081684A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017081684-A1 |
| Application number | US-201615248065-A |
| Country | US |
| Kind code | A1 |
| Filing date | Aug 26, 2016 |
| Priority date | Jun 19, 2002 |
| Publication date | Mar 23, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An improved pasteurisation protocol for pasteurising microbial cells is disclosed. The protocol has three stages, a first heating stage, a second plateau stage at which the cells are held at a (maximum and) constant temperature, and a third cooling stage. Both the heating and the cooling stages are rapid, with the temperature of the cells passing through 40 to 80° C. in no more than 30 minutes in the heating stage. The heating rate is at least 0.5° C./minute and during cooling is at least −0.5° C./minute. The plateau maximum temperature is from 70 to 85° C. By plotting the pasteurisation protocol on a time (t, minutes) versus temperature (T, ° C.) graph, one obtains a trapezium having an area less than 13,000° C. minute. Not only does this result in a smaller energy input (and so a reduction in costs), but a better quality (and less oxidised) oil results having a peroxide value (POV) of less than 1.5 and an anisidine value (AnV) of less than 1.0.
Opening claim text (preview).
1 . A process for pasteurizing microbial cells or microorganisms, the process comprising: (a) heating the cells or microorganisms from 40° C. to 60° C. in no more than 30 minutes or (b) heating the cells or microorganisms from 40° C. to 60° C. at a rate greater than 0.5° C./minute or (c) heating the cells or microorganisms from 40° C. to 60° C. in no more than 30 minutes at a rate greater than 0.5° C./minute or (d) heating the cells or microorganisms and maintaining the heated cells or microorganisms at an elevated temperature (T, ° C.) for a time (t, minutes) at a plateau stage, wherein the product T.t is from 140 to 100,800° C.minute. 2 . A process for pasteurizing microbial cells or microorganisms that comprises three stages, the process comprising: (a) a (first) heating stage, a (second) plateau stage at which the cells or microorganisms are maintained at a constant temperature, and (c) a (third) cooling stage. 3 . The process according to claim 1 or claim 2 , wherein a time versus temperature graph produces a trapezium having an area under the time (minutes) versus temperature (° C.) graph below 13,000° C.minute. 4 . The process according to claim 1 or claim 2 , wherein (a) the plateau stage is maintained at the maximum temperature, and/or (b) a time (t) versus temperature (T) graph produces a trapezium, and/or (c) the heating and/or cooling is a linear change in temperature, and/or (d) the cells or microorganisms are heated at a temperature starting below 40° C. and/or are heated to a temperature above 60° C., and/or (e) the cells or microorganisms comprise a PUFA or optionally comprise a PUFA-containing microbial oil. 5 . The process according to claim 1 or claim 2 , wherein the cells or microorganisms are heated from 40° C. to 60° C. in no more than 15 minutes and/or the cells or microorganisms are heated at a rate of at least 0.6 or 1.0° C./minute. 6 . The process according to claim 1 or claim 2 , wherein (a) the cells or microorganisms are heated at a rate of at least 2° C./minute; (b) the pasteurization or plateau temperature is from 60 to 100° C., or optionally from 60 to 85° C.; and/or (c) the cells or microorganisms are cooled at a rate of at least −0.6 or −1.6° C./minute; and/or (d) a time (t) versus temperature (T) graph has an area under he time (minutes) versus temperature (° C.) graph below 10,000 or 8,000° C.minute. 7 . A process for obtaining a PUFA or oil from microbial cells or microorganisms, the process comprising a process according to claim 1 or claim 2 and further comprising: extracting or isolating the PUFA or oil from the pasteurized cells or microorganisms. 8 . A process for pasteurizing microbial cells or microorganisms according to claim 2 , the process comprising: (a) heating the cells or microorganisms comprising (i) heating from 40° C. to 60° C. in no more than 30 minutes, or (ii) heating from 40° C. to 60° C. at a rate greater than 0.5° C./minute, or (iii) heating from 40° C. to 60° C. in no more than 30 minutes at a rate greater than 0.5° C./minute; (b) a plateau stage at which the cells or microorganisms are maintained at a constant temperature; and (c) cooling the cells or microorganisms. 9 . The process according to claim 1 or claim 2 , wherein the cells or microorganisms comprise a yeast, optionally a Pichia or a Saccharomyces ; a bacteria, optionally a Propionibacterium ; an algae, optionally a dinoflagellates, a Porphyridium , a Nitszchia , or a Crypthecodinium ; or, a fungi, optionally a Murorales , a Mortierella , a Phycomyces , a Blakeslea or an Aspergillus. 10 . A polyunsaturated fatty acid (PUFA) or microbial oil obtained by the process according to claim 7 . 11 . A microbial oil comprising a triglyceride content of at least 90%; a peroxide value (POV) of less than 1.5, or optionally less than 1.0; and/or an anisidine value (AnV) of less than 15, or optionally less than 12. 12 . The microbial oil of claim 11 wherein (a) PUFA comprises a C 18 , C 20 , or C 22 ω-3 or ω-6 fatty acid; (b) PUFA content is at least 40%; (c) PUFA comprises arachidonic acid (ARA), eicosapentaenoic acid (EPA), and/or docosahexaenoic acid (DHA); and/or (d) the oil is a crude or unrefined oil.
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Drugs for disorders of the nervous system · CPC title
Fungi, e.g. yeasts · CPC title
Algae · CPC title
Preparations for care of the skin · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.